Capgemini Has No Pathway for Significant Revenue Growth -- Market Talk
Dow Jones
Jan 12
1410 GMT - Capgemini lacks a compelling equity story, and there is no clear pathway for the French IT company to generate organic revenue growth above 3% over the next few years, analysts at Morgan Stanley write. Capgemini stock is more expensive relative to the company's earnings than market price, the analysts write as they expect larger cap IT names to struggle in 2026. Revenue will be hard to come by across the sector, with investors instead emphasizing earnings quality, they add. Generative AI will also trouble the sector's margins. Shares in Capgemini fall 4.4% to 144.25 euros. (josephmichael.stonor@wsj.com)
(END) Dow Jones Newswires
January 12, 2026 09:10 ET (14:10 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.